Meresasul (Sulpiride)

Sulpiride acts as a selective antagonist of dopamine D2 and D3 receptors, primarily in the limbic system and striatum. By blocking these receptors, it reduces excessive dopaminergic signaling that contributes to psychosis and mood disturbances, thereby helping to stabilize symptoms of schizophrenia, depression, and anxiety.

The dosage of Meresasul is individualized by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, renal function, and overall health status. Healthcare providers determine the appropriate dose and titration schedule, and patients should follow the prescriber’s instructions without self‑adjusting the regimen.

Safety data for sulpiride in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare professional.

To request Meresasul, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meresasul (sulpiride) belongs to the benzamide class and offers selective D2/D3 antagonism, which can result in a different side‑effect profile compared with broader‑acting atypical antipsychotics such as risperidone or olanzapine. It may be preferred when clinicians seek a medication with lower metabolic impact but must monitor for extrapyramidal symptoms and prolactin elevation.

Meresasul should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Meresasul is taken orally. Patients should swallow the tablet whole with a glass of water, with or without food, as directed by their prescriber. Consistency in administration time each day helps maintain stable drug levels, and any missed dose should be addressed according to the clinician’s guidance.

The most serious risks include neuroleptic malignant syndrome, a rare but life‑threatening condition characterized by fever, muscle rigidity, and autonomic instability; severe hyperprolactinemia, which can cause galactorrhea, menstrual disturbances, or sexual dysfunction; and cardiac arrhythmias that may require urgent medical attention.

Meresasul is contraindicated in individuals with known hypersensitivity to sulpiride or any benzamide compounds. It should also be avoided in patients with severe hepatic impairment, uncontrolled cardiac disease, or those taking medications that pose a high risk of dangerous interactions. Use in children and adolescents is not recommended without specialist supervision.